G F M Strippoli

Summary

Country: Italy

Publications

  1. ncbi request reprint Primary cerebral lymphoma and membranous nephropathy: a still unreported association
    Giovanni F M Strippoli
    Department of Emergency and Organ Transplantation, Division of Nephrology, University of Bari, Bari, Italy
    Am J Kidney Dis 39:E22. 2002
  2. ncbi request reprint Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials
    Giovanni F M Strippoli
    Centre for Kidney Research, National Health and Medical Research Council Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, Children s Hospital at Westmead, University of Sydney, Sydney, Australia
    Am J Kidney Dis 44:591-603. 2004
  3. ncbi request reprint Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials
    Giovanni F M Strippoli
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, Locked Bag 4001, University of Sydney, Australia
    J Am Soc Nephrol 15:2735-46. 2004
  4. ncbi request reprint [Search strategies for nephrology knowledge and evidence]
    G F M Strippoli
    Dipartimento dell Emergenza e dei Trapianti d Organo DETO, Sezione di Nefrologia, Universita degli Studi di Bari, Bari, Italy
    G Ital Nefrol 21:65-72. 2004
  5. ncbi request reprint Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials
    Giovanni F M Strippoli
    Centre for Kidney Research, NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, Locked Bag 4001, The Children s Hospital at Westmead and the University of Sydney, Westmead, NSW 2145, Australia
    J Am Soc Nephrol 15:3154-65. 2004
  6. ncbi request reprint The number, quality, and coverage of randomized controlled trials in nephrology
    Giovanni F M Strippoli
    NHMRC Centre of Clinical Research Excellence in Renal Medicine, The Children s Hospital at Westmead, School of Public Health, University of Sydney, Australia
    J Am Soc Nephrol 15:411-9. 2004
  7. ncbi request reprint [Critical appraisal of systematic reviews of randomised trials in nephrology: theory and practice for interpreting level I evidence]
    G F M Strippoli
    Divisione di Nefrologia, Dipartimento dell Emergenza e dei Trapianti d Organo, Universita degli Studi di Bari Policlinico, Bari, Italy
    G Ital Nefrol 20:615-24. 2003
  8. ncbi request reprint [Causality in nephrology: study design and objectives of future research]
    G F M Strippoli
    Dipartimento dell Emergenza e dei Trapianti d Organo DETO, Sezione di Nefrologia, Dialisi e Trapianto, Universita degli Studi di Bari, Italy
    G Ital Nefrol 20:503-11. 2003
  9. ncbi request reprint [Nephrology evidence and guidelines: current tools and several still open questions]
    G F M Strippoli
    Dipartimento dell Emergenza e dei Trapianti d Organo, Sezione di Nefrologia, Dialisi e Trapianto, Universita degli Studi di Bari, Italy
    G Ital Nefrol 20:271-9. 2003
  10. ncbi request reprint [Randomized controlled trials: a controversial past and a future of regulation and rejection]
    G F M Strippoli
    U O di Nefrologia, Dialisi e Trapianti, Dipartimento dell Emergenza e dei Trapianti d Organo, Universita degli Studi di Bari, Bari, Italy
    G Ital Nefrol 19:4-12. 2002

Collaborators

Detail Information

Publications40

  1. ncbi request reprint Primary cerebral lymphoma and membranous nephropathy: a still unreported association
    Giovanni F M Strippoli
    Department of Emergency and Organ Transplantation, Division of Nephrology, University of Bari, Bari, Italy
    Am J Kidney Dis 39:E22. 2002
    ..The absence of specific guidelines on this topic may be due partly to the lack of extensive description of all newly identified cases. All cases should be reported to evaluate whether this association is causal or fortuitous...
  2. ncbi request reprint Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials
    Giovanni F M Strippoli
    Centre for Kidney Research, National Health and Medical Research Council Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, Children s Hospital at Westmead, University of Sydney, Sydney, Australia
    Am J Kidney Dis 44:591-603. 2004
    ..Oral, nasal, and topical antibiotic prophylaxis; exit-site disinfectants; and other antimicrobial interventions are used to prevent it. This study was conducted to assess what evidence supports these approaches...
  3. ncbi request reprint Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials
    Giovanni F M Strippoli
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, Locked Bag 4001, University of Sydney, Australia
    J Am Soc Nephrol 15:2735-46. 2004
    ....
  4. ncbi request reprint [Search strategies for nephrology knowledge and evidence]
    G F M Strippoli
    Dipartimento dell Emergenza e dei Trapianti d Organo DETO, Sezione di Nefrologia, Universita degli Studi di Bari, Bari, Italy
    G Ital Nefrol 21:65-72. 2004
    ....
  5. ncbi request reprint Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials
    Giovanni F M Strippoli
    Centre for Kidney Research, NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, Locked Bag 4001, The Children s Hospital at Westmead and the University of Sydney, Westmead, NSW 2145, Australia
    J Am Soc Nephrol 15:3154-65. 2004
    ..There is insufficient data to guide decisions in patients without cardiovascular disease or in the predialysis population...
  6. ncbi request reprint The number, quality, and coverage of randomized controlled trials in nephrology
    Giovanni F M Strippoli
    NHMRC Centre of Clinical Research Excellence in Renal Medicine, The Children s Hospital at Westmead, School of Public Health, University of Sydney, Australia
    J Am Soc Nephrol 15:411-9. 2004
    ....
  7. ncbi request reprint [Critical appraisal of systematic reviews of randomised trials in nephrology: theory and practice for interpreting level I evidence]
    G F M Strippoli
    Divisione di Nefrologia, Dipartimento dell Emergenza e dei Trapianti d Organo, Universita degli Studi di Bari Policlinico, Bari, Italy
    G Ital Nefrol 20:615-24. 2003
    ..Systematic reviews represent the primary level of evidence (level I evidence) and an excellent answer to causality questions. They should be based upon high quality standards and the critical appraisal of such study design is fundamental...
  8. ncbi request reprint [Causality in nephrology: study design and objectives of future research]
    G F M Strippoli
    Dipartimento dell Emergenza e dei Trapianti d Organo DETO, Sezione di Nefrologia, Dialisi e Trapianto, Universita degli Studi di Bari, Italy
    G Ital Nefrol 20:503-11. 2003
    ..Causality has to be assessed by randomised controlled trials. However, since these are not always ethically or technically possible, other study designs such as cohort studies, case-control and cross-sectional analytic studies may be used...
  9. ncbi request reprint [Nephrology evidence and guidelines: current tools and several still open questions]
    G F M Strippoli
    Dipartimento dell Emergenza e dei Trapianti d Organo, Sezione di Nefrologia, Dialisi e Trapianto, Universita degli Studi di Bari, Italy
    G Ital Nefrol 20:271-9. 2003
    ....
  10. ncbi request reprint [Randomized controlled trials: a controversial past and a future of regulation and rejection]
    G F M Strippoli
    U O di Nefrologia, Dialisi e Trapianti, Dipartimento dell Emergenza e dei Trapianti d Organo, Universita degli Studi di Bari, Bari, Italy
    G Ital Nefrol 19:4-12. 2002
    ..The aim of this analysis is to provide clinical researchers with a valuable working tool. Finally, future guidelines for systematic reviews of randomized controlled studies are presented according to the Cochrane Collaboration model...
  11. pmc Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review
    Giovanni F M Strippoli
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, Children s Hospital at Westmead, Westmead, NSW 2145, Australia
    BMJ 329:828. 2004
    ..To evaluate the effects of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor antagonists (AIIRAs) on renal outcomes and all cause mortality in patients with diabetic nephropathy...
  12. ncbi request reprint [Evidence-based guidelines and nephrological clinical practice: the GRADE system for rating of evidence]
    C Bonifati
    Unità Operativa Complessa di Nefrologia, Dialisi e Trapianti, Dipartimento dell Emergenza e dei Trapianti d Organo, Universita degli Studi, Bari, Italy
    G Ital Nefrol 25:449-58. 2008
    ....
  13. ncbi request reprint Antimicrobial agents and catheter-related interventions to prevent peritonitis in peritoneal dialysis: Using evidence in the context of clinical practice
    C Bonifati
    Department of Emergency and Organ Transplantation, Division of Nephrology, University of Bari, Bari Italy
    Int J Artif Organs 29:41-9. 2006
    ..The broader adoption of several strategies, including antimicrobial and catheter related interventions, has been advocated to prevent or reduce the risk of peritonitis in peritoneal dialysis...
  14. ncbi request reprint [Chorea in hemodialysis: Is chorea just a neurological syndrome or is it related to uremia or dialysis?]
    G F M Strippoli
    Dipartimento dell Emergenza e dei Trapianti d Organo, Sezione di Nefrologia Universita degli Studi di Bari, Italy
    G Ital Nefrol 19:575-84. 2002
    ....
  15. ncbi request reprint [The Italian Society of Nephrology Guidelines (3rd Edition): principles and methods]
    C Manno
    Dipartimento dell Emergenza e dei Trapianti d Organo DETO, Sezione di Nefrologia, Universita degli Studi, Bari, Italy
    G Ital Nefrol 23:173-81. 2006
    ..The different phases of development and publication of the 3(rd) edition of the Italian Society of Nephrology guidelines are presented...
  16. ncbi request reprint [Patient satisfaction in hemodialysis: a pilot cross-sectional analysis and a review]
    F Pansini
    Dipartimento dell Emergenza e Trapianti d Organo DETO, Universita degli Studi, Bari, Italy
    G Ital Nefrol 24:584-94. 2007
    ..In this review, we discuss methodological aspects of assessment of patient satisfaction in hemodialysis. We also present a pilot study conducted in the Gambro Healthcare Italy dialysis clinics network...
  17. ncbi request reprint Haemoglobin targets: we were wrong, time to move on
    Giovanni F M Strippoli
    Cochrane Renal Group and Centre for Kidney Research and NHMRC Centre for Clinical Research Excellence in Renal Medicine, School of Public Health, University of Sydney, Sydney, New South Wales, Australia
    Lancet 369:346-50. 2007
  18. ncbi request reprint Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression
    Giovanni F M Strippoli
    National Health and Medical Research Council Centre for Clinical Research Excellence in Renal Medicine, University of Sydney, Australia
    J Am Soc Nephrol 17:S153-5. 2006
    ..On the basis of available RCT evidence, ACEi are the only agents with proven renal benefit in patients who have diabetes with no nephropathy and the only agents with proven survival benefit in patients who have diabetes with nephropathy...
  19. ncbi request reprint A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study
    Carlo Manno
    Department of Emergency and Organ Transplantation, Renal, Dialysis and Transplant Unit, University of Bari, Bari, Italy
    Am J Kidney Dis 49:763-75. 2007
    ..We evaluated factors associated with long-term renal survival by using a novel simplified histological classification...
  20. ncbi request reprint Antihypertensive agents for primary prevention of diabetic nephropathy
    Giovanni F M Strippoli
    Cochrane Renal Group, Centre for Kidney Research, Locked Bag 4001, Children s Hospital at Westmead, Westmead, NSW 2145, Australia
    J Am Soc Nephrol 16:3081-91. 2005
    ....
  21. ncbi request reprint An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism
    Giovanni F M Strippoli
    Department of Emergency and Organ Transplantation, Section of Nephrology, University of Bari, Bari, Italy
    Am J Kidney Dis 41:1129-39. 2003
    ..Severity of renal lesions, serum creatinine level, and severe proteinuria are adverse prognostic indicators. No specific treatment has been established, but several approaches have been experimented...
  22. pmc Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
    Giovanni F M Strippoli
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, School of Public Health, University of Sydney, Australia
    BMJ 336:645-51. 2008
    ..To analyse the benefits and harms of statins in patients with chronic kidney disease (pre-dialysis, dialysis, and transplant populations)...
  23. ncbi request reprint Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy
    Carlo Manno
    Department of Emergency and Organ Transplantation, Division of Nephrology, University of Bari, Bari, Italy
    Kidney Int 66:1570-7. 2004
    ..However, bleeding complications still occur, resulting in increased hospital stay and treatment costs...
  24. ncbi request reprint Is renal impairment a predictor of the incidence of cataract or cataract surgery? Findings from a population-based study
    Son C Huynh
    Centre for Vision Research, Department of Ophthalmology and Westmead Millennium Institute, University of Sydney, Sydney, NSW, Australia
    Ophthalmology 112:293-300. 2005
    ..To explore the relationship between creatinine clearance, an estimate of glomerular filtration rate, and 5-year incidence of cataract and cataract surgery...
  25. ncbi request reprint Meta-analysis of biochemical and patient-level effects of calcimimetic therapy
    Giovanni F M Strippoli
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, Cochrane Renal Group, School of Public Health, University of Sydney, Australia
    Am J Kidney Dis 47:715-26. 2006
    ..We conducted a meta-analysis to evaluate outcomes of therapy with these novel agents...
  26. ncbi request reprint Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials
    Elisabeth M Hodson
    National Health and Medical Research Council Centre for Clinical Research Excellence, Centre for Kidney Research, The Children s Hospital at Westmead, Sydney, Australia
    Lancet 365:2105-15. 2005
    ..We undertook a systematic review to investigate whether this approach affects risks of cytomegalovirus disease and death...
  27. ncbi request reprint Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients
    Giovanni F M Strippoli
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, Centre for Kidney Research, The Children s Hospital at Westmead, Sydney, Australia
    Transplantation 81:139-45. 2006
    ..This study was conducted to evaluate the efficacy of preemptive treatment in preventing symptomatic CMV disease...
  28. ncbi request reprint Hypothesis versus association: the optimal hemoglobin target debate
    Giovanni F M Strippoli
    Am J Kidney Dis 46:970-3. 2005
  29. ncbi request reprint Antihypertensive agents in patients with diabetes: trade-off between renal and cardiovascular protection
    Sankar D Navaneethan
    Division of Nephrology, University of Rochester, 601 Elmwood Drive, Box 675, Rochester, NY 14642, USA
    Diabetes Educ 32:596-602. 2006
    ..Use of any agent that provides tight control of blood pressure is indicated in patients with diabetes but without nephropathy...
  30. ncbi request reprint A pegylated epoetin in anaemia of renal disease: non-inferiority for an unvalidated surrogate
    Rowan G Walker
    North West Dialysis, Royal Melbourne Hospital, Melbourne, Vic, Australia
    Lancet 370:1395-6. 2007
  31. ncbi request reprint Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials
    Suetonia C Palmer
    Department of Nephrology, Christchurch Hospital, Christchurch, New Zealand
    Am J Kidney Dis 45:638-49. 2005
    ..This study was conducted to assess the evidence available to guide targeted treatment to reduce bone disease in transplant recipients...
  32. doi request reprint The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial
    Antonio Santoro
    Nephrology, Dialysis, and Hypertension Department, Policlinico S Orsola Malpighi, Bologna, Italy
    Am J Kidney Dis 52:507-18. 2008
    ....
  33. ncbi request reprint Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials
    Joshua A Samuels
    UT Houston Health Science Center, Houston Texas, USA
    Nephrology (Carlton) 9:177-85. 2004
    ..43). Although the optimal management of patients with IgA nephropathy remains uncertain because of limitations with the existing published data, immunosuppressive agents are a promising strategy and should be investigated further...
  34. ncbi request reprint Meta-analysis: vitamin D compounds in chronic kidney disease
    Suetonia C Palmer
    Department of Medicine, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand
    Ann Intern Med 147:840-53. 2007
    ..Vitamin D compounds are widely used to prevent and treat secondary hyperparathyroidism...
  35. ncbi request reprint Treatment of peritoneal dialysis-associated peritonitis: a systematic review of randomized controlled trials
    Kathryn J Wiggins
    Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    Am J Kidney Dis 50:967-88. 2007
    ..Peritonitis frequently complicates peritoneal dialysis. Appropriate treatment is essential to reduce adverse outcomes. Available trial evidence about peritoneal dialysis peritonitis treatment was evaluated...
  36. ncbi request reprint Sevelamer: a promising but unproven drug
    Suetonia C Palmer
    Nephrol Dial Transplant 22:2742-5. 2007
  37. ncbi request reprint Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study
    Monica Franciosi
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Via Nazionale, 66030 S Maria Imbaro CH, Italy
    Clin J Am Soc Nephrol 2:984-91. 2007
    ..The objective of this study was to investigate correlates of risk for having microalbuminuria in individuals with one or more cardiovascular risk factors...
  38. pmc Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials
    Sankar D Navaneethan
    Department of Medicine, Unity Health System, Rochester, New York, United States of America
    PLoS Med 3:e123. 2006
  39. ncbi request reprint Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review
    Kannaiyan S Rabindranath
    Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, UK
    Am J Kidney Dis 45:437-47. 2005
    ....
  40. ncbi request reprint Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials
    Robert S Flanc
    Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
    Am J Kidney Dis 43:197-208. 2004
    ..In this systematic review of randomized controlled trials (RCTs), we assess the benefits and harm of current treatments for diffuse proliferative lupus nephritis (DPLN)...